Page last updated: 2024-09-05

asperflavin and kojic acid

asperflavin has been researched along with kojic acid in 1 studies

Compound Research Comparison

Studies
(asperflavin)
Trials
(asperflavin)
Recent Studies (post-2010)
(asperflavin)
Studies
(kojic acid)
Trials
(kojic acid)
Recent Studies (post-2010) (kojic acid)
50264610369

Protein Interaction Comparison

ProteinTaxonomyasperflavin (IC50)kojic acid (IC50)
Polyphenol oxidase 2Agaricus bisporus9.2
D-amino-acid oxidaseSus scrofa (pig)2
TyrosinaseHomo sapiens (human)8.275
D-amino-acid oxidaseHomo sapiens (human)2
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)2
Alpha-1D adrenergic receptorRattus norvegicus (Norway rat)2
Alpha-1B adrenergic receptorHomo sapiens (human)8.33
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)2

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aree, T; Ganihigama, DU; Hongmanee, P; Kittakoop, P; Mahidol, C; Ruchirawat, S; Sangher, S; Sureram, S1

Other Studies

1 other study(ies) available for asperflavin and kojic acid

ArticleYear
Antimycobacterial activity of natural products and synthetic agents: pyrrolodiquinolines and vermelhotin as anti-tubercular leads against clinical multidrug resistant isolates of Mycobacterium tuberculosis.
    European journal of medicinal chemistry, 2015, Jan-07, Volume: 89

    Topics: Antitubercular Agents; Biological Products; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Pyrrolidines; Quinolines; Structure-Activity Relationship

2015